- Home
- NEPH vs SLGL Comparison
NEPH vs SLGL Comparison
Compare NEPH & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEPH
- SLGL
- Stock Information
- Founded
- NEPH 1997
- SLGL 1997
- Country
- NEPH United States
- SLGL Israel
- Employees
- NEPH N/A
- SLGL N/A
- Industry
- NEPH Medical/Dental Instruments
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- NEPH Health Care
- SLGL Health Care
- Exchange
- NEPH Nasdaq
- SLGL Nasdaq
- Market Cap
- NEPH 15.9M
- SLGL 18.3M
- IPO Year
- NEPH 2004
- SLGL 2018
- Fundamental
- Price
- NEPH $1.54
- SLGL $0.43
- Analyst Decision
- NEPH Buy
- SLGL Strong Buy
- Analyst Count
- NEPH 1
- SLGL 2
- Target Price
- NEPH $5.00
- SLGL $5.00
- AVG Volume (30 Days)
- NEPH 9.8K
- SLGL 54.0K
- Earning Date
- NEPH 11-07-2024
- SLGL 11-15-2024
- Dividend Yield
- NEPH N/A
- SLGL N/A
- EPS Growth
- NEPH N/A
- SLGL N/A
- EPS
- NEPH N/A
- SLGL N/A
- Revenue
- NEPH $13,546,000.00
- SLGL $11,707,000.00
- Revenue This Year
- NEPH N/A
- SLGL $500.51
- Revenue Next Year
- NEPH $9.13
- SLGL N/A
- P/E Ratio
- NEPH N/A
- SLGL N/A
- Revenue Growth
- NEPH 0.03
- SLGL 869.93
- 52 Week Low
- NEPH $1.36
- SLGL $0.33
- 52 Week High
- NEPH $4.04
- SLGL $1.58
- Technical
- Relative Strength Index (RSI)
- NEPH 47.64
- SLGL 33.32
- Support Level
- NEPH $1.53
- SLGL $0.44
- Resistance Level
- NEPH $1.64
- SLGL $0.51
- Average True Range (ATR)
- NEPH 0.06
- SLGL 0.04
- MACD
- NEPH -0.01
- SLGL -0.01
- Stochastic Oscillator
- NEPH 37.50
- SLGL 11.69
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.